Cataracts are 1 of 4 “hallmark manifestations” of cerebrotendinous xanthomatosis (CTX), a rare genetic disorder that affects the body’s ability to metabolize cholesterols. During the National Lipid Association Scientific Sessions, Ernst Schaefer, MD;...

A customized version of GPT-4 has demonstrated high accuracy and sensitivity in determining patient eligibility for retina-specific clinical trials, suggesting that this technology could significantly streamline the process of qualifying patients for clinical...

Timrepigene emparvovec, a gene therapy for choroideremia, has demonstrated safety and efficacy in maintaining visual acuity when administered bilaterally, according to a study. The therapy was well tolerated with mostly mild to moderate...

Previous treatment with laser trabeculoplasty (LTP) does not influence the outcomes of subsequent phacoemulsification combined with Kahook Dual Blade goniotomy (phaco-KDB) in patients with open-angle glaucoma or intraocular hypertension, according to a study....

Bausch + Lomb Corporation announced the acquisition of Trukera Medical, a United States-based ophthalmic medical diagnostic company, according to a press release. Trukera Medical, previously owned by AccelMed Partners and other shareholders, is...

Geographic atrophy in eyes with dry age-related macular degeneration (dAMD) and macular atrophy in fellow eyes with neovascular AMD (nAMD), treated with anti-VEGF injections, exhibit similar growth rates, according to a poster presented...

Bausch + Lomb Corporation announced the acquisition of Trukera Medical, a United States-based ophthalmic medical diagnostic company, according to a press release. Trukera Medical, previously owned by AccelMed Partners and other shareholders, is...